Phase 1 Non Muscle Invasive Bladder Cancer Clinical Trials
2 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–2 of 2 trials
Recruiting
Phase 1Phase 2
A Study of Intravesical BCG in Combination With ALT-803 in Patients With Non-Muscle Invasive Bladder Cancer
Non Muscle Invasive Bladder Cancer
ImmunityBio, Inc.596 enrolled80 locationsNCT02138734
Completed
Phase 1
SUBurothelial DUrvalumab injEction-1 (SUBDUE-1)
Muscle invasive or high risk non muscle invasive bladder cancer
South Metropolitan Health Service12 enrolled1 locationACTRN12620000063910